| __timestamp | Amphastar Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 55402000 |
| Thursday, January 1, 2015 | 77347000 | 66107000 |
| Friday, January 1, 2016 | 104189000 | 103402000 |
| Sunday, January 1, 2017 | 90795000 | 135736000 |
| Monday, January 1, 2018 | 106985000 | 245116000 |
| Tuesday, January 1, 2019 | 131923000 | 108935000 |
| Wednesday, January 1, 2020 | 143340000 | 156000000 |
| Friday, January 1, 2021 | 199739000 | 214957000 |
| Saturday, January 1, 2022 | 248860000 | 143418000 |
| Sunday, January 1, 2023 | 351121000 | 96265000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, financial performance is a key indicator of success. Over the past decade, Ligand Pharmaceuticals Incorporated and Amphastar Pharmaceuticals, Inc. have been vying for dominance in gross profit generation. From 2014 to 2023, Amphastar has shown a remarkable upward trend, culminating in a 2023 gross profit that is approximately 3.5 times higher than its 2014 figure. Ligand, on the other hand, experienced a peak in 2018, with a gross profit nearly 2.5 times its 2014 value, before seeing a decline in subsequent years.
This financial narrative highlights the dynamic nature of the pharmaceutical industry, where strategic decisions and market conditions can significantly impact a company's financial trajectory. As investors and industry watchers look to the future, the question remains: will Amphastar maintain its momentum, or will Ligand stage a comeback?
Gross Profit Trends Compared: AbbVie Inc. vs Ligand Pharmaceuticals Incorporated
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
United Therapeutics Corporation vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Jazz Pharmaceuticals plc vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends